{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:01:56Z","timestamp":1788184916657,"version":"build-2803163510"},"reference-count":39,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2023,1,1]]},"abstract":"<jats:sec id=\"ab-hoi220069-4\"><jats:title>Importance<\/jats:title><jats:p>Thoracic endovascular aortic repair (TEVAR) has increasingly been used for uncomplicated type B aortic dissection (uTBAD) despite limited supporting data.<\/jats:p><\/jats:sec><jats:sec id=\"ab-hoi220069-5\"><jats:title>Objective<\/jats:title><jats:p>To assess whether initial TEVAR following uTBAD is associated with reduced mortality or morbidity compared with medical therapy alone.<\/jats:p><\/jats:sec><jats:sec id=\"ab-hoi220069-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This cohort study included Centers for Medicare &amp;amp;amp; Medicaid Services inpatient claims data for adults aged 65 years or older with index admissions for acute uTBAD from January 1, 2011, to December 31, 2018, with follow-up available through December 31, 2019.<\/jats:p><\/jats:sec><jats:sec id=\"ab-hoi220069-7\"><jats:title>Exposures<\/jats:title><jats:p>Initial TEVAR was defined as TEVAR within 30 days of admission for acute uTBAD.<\/jats:p><\/jats:sec><jats:sec id=\"ab-hoi220069-8\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>Outcomes included all-cause mortality, cardiovascular hospitalizations, aorta-related and repeated aorta-related hospitalizations, and aortic interventions associated with initial TEVAR vs medical therapy. Propensity score inverse probability weighting was used.<\/jats:p><\/jats:sec><jats:sec id=\"ab-hoi220069-9\"><jats:title>Results<\/jats:title><jats:p>Of 7105 patients with eligible index admissions for acute uTBAD, 1140 (16.0%) underwent initial TEVAR (623 [54.6%] female; median age, 74 years [IQR, 68-80 years]) and 5965 (84.0%) did not undergo TEVAR (3344 [56.1%] female; median age, 76 years [IQR, 69-83 years]). Receipt of TEVAR was associated with region (vs South; Midwest: adjusted odds ratio [aOR], 0.66 [95% CI, 0.53-0.81]; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001; Northeast: aOR, 0.63 [95% CI, 0.50-0.79]; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001), Medicaid dual eligibility (aOR, 0.76; 95% CI, 0.63-0.91; <jats:italic>P<\/jats:italic>\u2009=\u2009.003), hypertension (aOR, 1.26; 95% CI, 1.03-1.54; <jats:italic>P<\/jats:italic>\u2009=\u2009.03), peripheral vascular disease (aOR, 1.24; 95% CI, 1.02-1.49; <jats:italic>P<\/jats:italic>\u2009=\u2009.03), and year of admission (2012, 2013, 2014, and 2015 were associated with greater odds of TEVAR compared with 2011). After inverse probability weighting, mortality was similar for the 2 strategies up to 5 years (hazard ratio [HR], 0.95; 95% CI, 0.85-1.06), as were aorta-related hospitalizations (HR, 1.12; 95% CI, 0.99-1.27), aortic interventions (HR, 1.01; 95% CI, 0.84-1.20), and cardiovascular hospitalizations (HR, 1.05; 95% CI, 0.93-1.20). In a sensitivity analysis that included deaths within the first 30 days, initial TEVAR was associated with lower mortality over a period of 1 year (adjusted HR [aHR], 0.86; 95% CI, 0.75-0.99; <jats:italic>P<\/jats:italic>\u2009=\u2009.03), 2 years (aHR, 0.85; 95% CI, 0.75-0.96; <jats:italic>P<\/jats:italic>\u2009=\u2009.008), and 5 years (aHR, 0.87; 95% CI, 0.80-0.96; <jats:italic>P<\/jats:italic>\u2009=\u2009.004).<\/jats:p><\/jats:sec><jats:sec id=\"ab-hoi220069-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>In this study, 16.0% of patients underwent initial TEVAR within 30 days of uTBAD, and receipt of initial TEVAR was associated with hypertension, peripheral vascular disease, region, Medicaid dual eligibility, and year of admission. Initial TEVAR was not associated with improved mortality or reduced hospitalizations or aortic interventions over a period of 5 years, but in a sensitivity analysis that included deaths within the first 30 days, initial TEVAR was associated with lower mortality. These findings, along with cost-effectiveness and quality of life, should be assessed in a prospective trial in the US population.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamacardio.2022.4187","type":"journal-article","created":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T16:30:43Z","timestamp":1667665843000},"page":"44","source":"Crossref","is-referenced-by-count":38,"title":["Initial Thoracic Endovascular Aortic Repair vs Medical Therapy for Acute Uncomplicated Type B Aortic Dissection"],"prefix":"10.1001","volume":"8","author":[{"given":"E. Hope","family":"Weissler","sequence":"first","affiliation":[{"name":"Division of Vascular and Endovascular Surgery, Duke University School of Medicine, Durham, North Carolina"},{"name":"Duke Clinical Research Institute, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oyomoare L.","family":"Osazuwa-Peters","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa A.","family":"Greiner","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. Chantelle","family":"Hardy","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Kougias","sequence":"additional","affiliation":[{"name":"Division of Vascular and Endovascular Surgery, SUNY Downstate Health Sciences University, Brooklyn, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M.","family":"O\u2019Brien","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel B.","family":"Mark","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Durham, North Carolina"},{"name":"Division of Cardiology, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Schuyler","family":"Jones","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Durham, North Carolina"},{"name":"Division of Cardiology, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Secemsky","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Vekstein","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Durham, North Carolina"},{"name":"Division of Cardiovascular and Thoracic Surgery, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherene","family":"Shalhub","sequence":"additional","affiliation":[{"name":"Division of Vascular Surgery, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firas F.","family":"Mussa","sequence":"additional","affiliation":[{"name":"Section of Vascular Surgery, Imperial College London, London, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manesh R.","family":"Patel","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Durham, North Carolina"},{"name":"Division of Cardiology, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreekanth","family":"Vemulapalli","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Durham, North Carolina"},{"name":"Division of Cardiology, Duke University School of Medicine, Durham, North Carolina"},{"name":"Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"6","key":"hoi220069r1","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1016\/j.jtcvs.2017.11.105","article-title":"Epidemiology and management of thoracic aortic dissections and thoracic aortic aneurysms in Ontario, Canada: a population-based study.","volume":"155","author":"McClure","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"hoi220069r2","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ejcts.2010.02.038","article-title":"Outcome of patients suffering from acute type B aortic dissection: a retrospective single-centre analysis of 135 consecutive patients.","volume":"38","author":"Garbade","year":"2010","journal-title":"Eur J Cardiothorac Surg"},{"issue":"4","key":"hoi220069r3","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.jtcvs.2021.11.091","article-title":"The Society of Thoracic Surgeons\/American Association for Thoracic Surgery clinical practice guidelines on the management of type B aortic dissection.","volume":"163","author":"MacGillivray","year":"2022","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"hoi220069r4","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.jtcvs.2017.04.064","article-title":"Prognostic significance of early aortic remodeling in acute uncomplicated type B aortic dissection and intramural hematoma.","volume":"154","author":"Sailer","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"8","key":"hoi220069r5","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1161\/CIRCULATIONAHA.115.015302","article-title":"Outcomes of patients with acute type B (DeBakey III) aortic dissection: a 13-year, single-center experience.","volume":"132","author":"Afifi","year":"2015","journal-title":"Circulation"},{"issue":"1","key":"hoi220069r6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ejvs.2016.06.005","article-title":"Editor\u2019s choice\u2014management of descending thoracic aorta diseases: clinical practice guidelines of the European Society for Vascular Surgery (ESVS).","volume":"53","author":"Riambau","year":"2017","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"25","key":"hoi220069r7","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1161\/CIRCULATIONAHA.109.886408","article-title":"Randomized comparison of strategies for type B aortic dissection: the Investigation of Stent Grafts in Aortic Dissection (INSTEAD) trial.","volume":"120","author":"Nienaber","year":"2009","journal-title":"Circulation"},{"issue":"4","key":"hoi220069r8","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1161\/CIRCINTERVENTIONS.113.000463","article-title":"Endovascular repair of type B aortic dissection: long-term results of the randomized investigation of stent grafts in aortic dissection trial.","volume":"6","author":"Nienaber","year":"2013","journal-title":"Circ Cardiovasc Interv"},{"issue":"3","key":"hoi220069r9","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ejvs.2014.05.012","article-title":"Endovascular repair of acute uncomplicated aortic type B dissection promotes aortic remodelling: 1 year results of the ADSORB trial.","volume":"48","author":"Brunkwall","year":"2014","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"8","key":"hoi220069r10","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1002\/clc.v44.8","article-title":"National trends in repair for type B aortic dissection.","volume":"44","author":"Weissler","year":"2021","journal-title":"Clin Cardiol"},{"issue":"21","key":"hoi220069r11","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1161\/CIRCULATIONAHA.106.622340","article-title":"Long-term survival in patients presenting with type B acute aortic dissection: insights from the International Registry of Acute Aortic Dissection.","volume":"114","author":"Tsai","year":"2006","journal-title":"Circulation"},{"issue":"5","key":"hoi220069r12","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.jvs.2014.12.038","article-title":"The natural history of medically managed acute type B aortic dissection.","volume":"61","author":"Durham","year":"2015","journal-title":"J Vasc Surg"},{"issue":"8","key":"hoi220069r13","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.jcin.2013.05.003","article-title":"Survival after endovascular therapy in patients with type B aortic dissection: a report from the International Registry of Acute Aortic Dissection (IRAD).","volume":"6","author":"Fattori","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"issue":"24","key":"hoi220069r14","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1016\/j.jacc.2016.03.578","article-title":"Endovascular repair compared with medical management of patients with uncomplicated type B acute aortic dissection.","volume":"67","author":"Qin","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"hoi220069r15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jtcvs.2019.11.127","article-title":"Comparison of mid-term outcomes of endovascular repair and medical management in patients with acute uncomplicated type B aortic dissection.","volume":"162","author":"Xiang","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"hoi220069r16","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1177\/1538574413518122","article-title":"Nationwide comparative impact of thoracic endovascular aortic repair of acute uncomplicated type B aortic dissections.","volume":"48","author":"Shah","year":"2014","journal-title":"Vasc Endovascular Surg"},{"issue":"6","key":"hoi220069r17","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1161\/CIRCOUTCOMES.114.001140","article-title":"Trends in aortic dissection hospitalizations, interventions, and outcomes among Medicare beneficiaries in the United States, 2000-2011.","volume":"7","author":"Mody","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"2","key":"hoi220069r18","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ejvs.2020.04.005","article-title":"Surgical decision making in uncomplicated type B aortic dissection: a survey of Australian\/New Zealand and European surgeons.","volume":"60","author":"Munshi","year":"2020","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"1","key":"hoi220069r19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jvs.2019.08.280","article-title":"Readmissions after acute type B aortic dissection.","volume":"72","author":"Carroll","year":"2020","journal-title":"J Vasc Surg"},{"issue":"8","key":"hoi220069r20","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke statistics-2021 update: a report from the American Heart Association.","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"issue":"5","key":"hoi220069r21","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1097\/01.mlr.0000160417.39497.a9","article-title":"Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors.","volume":"43","author":"Birman-Deych","year":"2005","journal-title":"Med Care"},{"issue":"11","key":"hoi220069r22","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"issue":"6","key":"hoi220069r23","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1016\/j.jvs.2022.01.010","article-title":"Racial disparities in presentation and short-term outcomes for patients with acute type B aortic dissection.","volume":"75","author":"Sorour","year":"2022","journal-title":"J Vasc Surg"},{"issue":"7","key":"hoi220069r24","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1097\/MLR.0000000000000729","article-title":"Development of a claims-based frailty indicator anchored to a well-established frailty phenotype.","volume":"55","author":"Segal","year":"2017","journal-title":"Med Care"},{"key":"hoi220069r25","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100183","article-title":"Association of entirely claims-based frailty indices with long-term outcomes in patients with acute myocardial infarction, heart failure, or pneumonia: a nationwide cohort study in Turkey.","volume":"10","author":"Kundi","year":"2021","journal-title":"Lancet Reg Health Eur"},{"issue":"24","key":"hoi220069r26","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.023138","article-title":"Association of frailty with treatment selection and long-term outcomes among patients with chronic limb-threatening ischemia.","volume":"10","author":"Butala","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"hoi220069r27","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of K-sample tests for comparing the cumulative incidence of a competing risk.","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat"},{"issue":"27","key":"hoi220069r28","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1002\/sim.v36.27","article-title":"Practical recommendations for reporting Fine-Gray model analyses for competing risk data.","volume":"36","author":"Austin","year":"2017","journal-title":"Stat Med"},{"issue":"4","key":"hoi220069r29","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1214\/aos\/1176345976","article-title":"Cox\u2019s regression model for counting processes: a large sample study.","volume":"10","author":"Andersen","year":"1982","journal-title":"Ann Stat"},{"issue":"1","key":"hoi220069r30","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/ije\/dyu222","article-title":"Modelling recurrent events: a tutorial for analysis in epidemiology.","volume":"44","author":"Amorim","year":"2015","journal-title":"Int J Epidemiol"},{"issue":"4","key":"hoi220069r31","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.ahj.2004.05.060","article-title":"Investigation of Stent Grafts in Patients With Type B Aortic Dissection: design of the INSTEAD trial\u2014a prospective, multicenter, European randomized trial.","volume":"149","author":"Nienaber","year":"2005","journal-title":"Am Heart J"},{"issue":"4","key":"hoi220069r32","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.jvs.2010.05.008","article-title":"Open and endovascular repair of type B aortic dissection in the nationwide inpatient sample.","volume":"52","author":"Sachs","year":"2010","journal-title":"J Vasc Surg"},{"issue":"6","key":"hoi220069r33","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/j.jvs.2018.04.034","article-title":"Favorable impact of thoracic endovascular aortic repair on survival of patients with acute uncomplicated type B aortic dissection.","volume":"68","author":"Iannuzzi","year":"2018","journal-title":"J Vasc Surg"},{"issue":"1","key":"hoi220069r34","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jvs.2020.04.499","article-title":"Cause-specific mortality of type B aortic dissection and assessment of competing risks of mortality.","volume":"73","author":"Hysa","year":"2021","journal-title":"J Vasc Surg"},{"issue":"16","key":"hoi220069r35","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1016\/j.jacc.2012.11.072","article-title":"Interdisciplinary expert consensus document on management of type B aortic dissection.","volume":"61","author":"Fattori","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"hoi220069r36","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.jvs.2015.04.423","article-title":"Aneurysmal degeneration of the thoracoabdominal aorta after medical management of type B aortic dissections.","volume":"62","author":"Durham","year":"2015","journal-title":"J Vasc Surg"},{"issue":"3","key":"hoi220069r37","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.jvs.2017.06.067","article-title":"Aneurysmal degeneration of type B aortic dissections after thoracic endovascular aortic repair: a systematic review.","volume":"66","author":"Famularo","year":"2017","journal-title":"J Vasc Surg"},{"issue":"1","key":"hoi220069r38","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ejcts.2007.10.010","article-title":"Serious complications following endovascular thoracic aortic stent-graft repair for type B dissection.","volume":"33","author":"Neuhauser","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"issue":"5","key":"hoi220069r39","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1016\/j.jtcvs.2014.03.013","article-title":"Insurance status predicts acuity of thoracic aortic operations.","volume":"148","author":"Andersen","year":"2014","journal-title":"J Thorac Cardiovasc Surg"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2798243\/jamacardiology_weissler_2022_oi_220069_1672335575.0569.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T16:16:09Z","timestamp":1673453769000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2798243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2022.4187","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,1]]}}}